Tag - retired people

ALS patients contend with $158K price tag on new drug


Washington: For two years, Becky Mourey pushed the Food and Drug Administration to approve an experimental drug for Lou Gehrig’s disease. She went to members of Congress and health regulators to make the case for Relyvrio, until patient-advocates finally prevailed. In September, Relyvrio became only the third drug approved in the U.S. for ALS, or amyotrophic lateral sclerosis,...